Publication | Closed Access

Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study

Oncologic ImagingAnti-cea Bispecific AntibodyMedicineGallium-68-labelled Imp-288 PeptidePathologyColorectal CancerColorectal Cancer MetastasesCancer TreatmentOncologyRadiation OncologyNuclear MedicineRadiologyHealth Sciences